Novartis unveiled a corporate restructuring that is consolidating some operations in cash-saving moves expected to lead to $1 billion in annual savings. The shakeup means the departure of several key executives, including Chief Medical Officer John Tsai, who has held that role since 2018.
The FDA placed a partial hold on a Curis drug in development for treating leukemia after a patient treated in a clinical trial died. The biotech company said the patient experienced a complication that is a known risk of the small molecule drug.
AI's ability to quickly scan and synthesize huge volumes of information is being adopted for numerous healthcare initiatives, including use in pharmaceutical drug discovery and development.
Director of payer sales at Ovia Health, Kami Wigginton, experienced discriminatory care first-hand when she had cervical cerclage surgery and labored for 30 hours during her first pregnancy. She weighs in on racism in maternity care and Ovia's mission to support families through pregnancy.
Metagenomics offers advances for infectious disease diagnostics by providing the diagnostic technology to detect a potentially unlimited numbers of known and novel microbes from a single sample in one test.
No comments